Serum Trough IgG level and Annual Intravenous Immunoglobulin Dose Are Not Related to Body Size in Patients on Regular Replacement Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|5|2|132-136

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.5, Iss.2, 2011-04, pp. : 132-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease: An Open-Label Prospective Study

By Kasztalska Karolina  

Clinical Drug Investigation, Vol. 31, Iss. 5, 2011-05 ,pp. : 299-307

Adis International

Access to resources Recommend Favorite

Commentary: Intravenous Immunoglobulin (IVIG) Therapy for Patients with Langerhans Cell Histiocytosis (LCH)-Related Neurodegenerative Diseases of the CNS

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 688-690

Bentham Science Publishers

Access to resources Recommend Favorite

Adverse Effects of Intravenous Immunoglobulin Therapy

By Nydegger U.E.  

Drug Safety, Vol. 21, Iss. 3, 1999-09 ,pp. : 171-185

Adis International

Access to resources Recommend Favorite

Intravenous Immunoglobulin Therapy in Dermatologic Disorders

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 2, 2008-06 ,pp. : 75-84

Bentham Science Publishers

Access to resources Recommend Favorite

Detection and Characterization of Subvisible Aggregates of Monoclonal IgG in Serum

By Filipe Vasco  

Pharmaceutical Research, Vol. 29, Iss. 8, 2012-08 ,pp. : 2202-2212

Springer Publishing Company

Access to resources Recommend Favorite